# Piloting Treatment With Intranasal Oxytocin in Phelan-McDermid Syndrome

> **NCT02710084** · PHASE2 · COMPLETED · sponsor: **Alexander Kolevzon** · enrollment: 18 (actual)

## Conditions studied

- Phelan-McDermid Syndrome

## Interventions

- **DRUG:** Oxytocin
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT02710084
- **Lead sponsor:** Alexander Kolevzon
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-29
- **Primary completion:** 2020-07-29
- **Final completion:** 2020-07-29
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2021-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02710084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02710084, "Piloting Treatment With Intranasal Oxytocin in Phelan-McDermid Syndrome". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02710084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*